164 related articles for article (PubMed ID: 791447)
1. Chemoimmunotherapy of advanced breast cancer: prolongation of remission and survival with BCG.
Gutterman JU; Cardenas JO; Blumenschein GR; Hortobagyi G; Burgess MA; Livingston RB; Mavligit GM; Freireich EJ; Gottlieb JA; Hersh EM
Br Med J; 1976 Nov; 2(6046):1222-5. PubMed ID: 791447
[TBL] [Abstract][Full Text] [Related]
2. Combination chemoimmunotherapy of metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, and BCG.
Hortobagyi GN; Gutterman JU; Blumenschein GR; Tashima CK; Burgess MA; Einhorn L; Buzdar AU; Richman SP; Hersh EM
Cancer; 1979 Nov; 44(5):1955-62. PubMed ID: 387212
[TBL] [Abstract][Full Text] [Related]
3. Response of disseminated breast cancer to combined modality treatment with chemotherapy and levamisole with or without Bacillus Calmette-Guérin.
Hortobagyi GN; Yap HY; Blumenschein GR; Gutterman JU; Buzdar AU; Tashima CK; Hersh EM
Cancer Treat Rep; 1978 Nov; 62(11):1685-92. PubMed ID: 728894
[TBL] [Abstract][Full Text] [Related]
4. Combination chemoimmunotherapy of metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, and BCG.
Hortobagyi GN; Gutterman JU; Blumenschein GR; Tashima CK; Burgess MA; Einhorn L; Buzdar AU; Richman SP; Hersh EM
Cancer; 1979 Apr; 43(4):1225-33. PubMed ID: 445325
[TBL] [Abstract][Full Text] [Related]
5. Combined chemoimmunotherapy for advanced breast cancer: a comparison of BCG and levamisole.
Hortobagyi GN; Gutterman JU; Blumenschein GR; Yap HY; Buzdar AU; Tashima CK; Burgess MA; Hersh EM
Cancer; 1979 Mar; 43(3):1112-22. PubMed ID: 427716
[TBL] [Abstract][Full Text] [Related]
6. Intensive postoperative chemoimmunotherapy for patients with stage II and stage III breast cancer.
Buzdar AU; Gutterman JU; Blumenschein GR; Hortobagyi GN; Tashima CK; Smith TL; Hersh EM; Freireich EJ; Gehan EA
Cancer; 1978 Mar; 41(3):1064-75. PubMed ID: 638948
[TBL] [Abstract][Full Text] [Related]
7. Treatment of locoregionally advanced breast cancer with surgery, radiotherapy, and combination chemoimmunotherapy.
Hortobagyi GN; Spanos W; Montague ED; Buzdar AU; Yap HY; Blumenschein GR
Int J Radiat Oncol Biol Phys; 1983 May; 9(5):643-50. PubMed ID: 6343312
[TBL] [Abstract][Full Text] [Related]
8. Combined chemoimmunotherapy and radiation therapy of inflammatory breast carcinoma.
Krutchik AN; Buzdar AU; Blumenschein GR; Hortobagyi GN; Tashima CK; Gutterman JU; Yap HY; Hersh EM
J Surg Oncol; 1979; 11(4):325-32. PubMed ID: 109703
[TBL] [Abstract][Full Text] [Related]
9. Chemoimmunotherapy with or without oophorectomy in premenopausal patients with advanced breast cancer.
Yap HY; Hortobagyi GN; Blumenschein GR; Tashima CK; Buzdar AU; Krutchik AN; Benjamin RS; Gutterman JU; Bodey GP
J Surg Oncol; 1979 Dec; 12(4):333-41. PubMed ID: 392197
[TBL] [Abstract][Full Text] [Related]
10. Combination chemoimmunotherapy with FAC-BCG for metastatic breast cancer: the impact of CMF maintenance chemotherapy.
Hortobagyi GN; Blumenschein GR; Buzdar AU; Yap HY; Schell FC; Barnes BC; Burgess MA
J Surg Oncol; 1981; 18(2):163-72. PubMed ID: 7300363
[TBL] [Abstract][Full Text] [Related]
11. Chemo immunotherapy of advanced breast cancer with BCG.
Hortobagyi GN; Gutterman JU; Blumenschein GR; Buzdar A; Burgess MA; Richman SP; Tashima CK; Schwarz M; Hersh EM
Recent Results Cancer Res; 1977; (62):143-50. PubMed ID: 601328
[No Abstract] [Full Text] [Related]
12. [Adriamycin, cyclophosphamide, and 5-fluorouracil in the treatment of metastasizing breast cancer (author's transl)].
Höffken K; Seeber S; Boecker WR; Schmidt CG
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1976 Jun; 86(2):135-45. PubMed ID: 132786
[TBL] [Abstract][Full Text] [Related]
13. Ifosfamide versus cyclophosphamide in combination drug therapy for metastatic breast cancer.
Buzdar AU; Legha SS; Tashima CK; Yap HY; Hortobagyi GN; Hersh EM; Blumenschein GR; Bodey GP
Cancer Treat Rep; 1979 Jan; 63(1):115-20. PubMed ID: 369682
[TBL] [Abstract][Full Text] [Related]
14. Ftorafur, adriamycin, cyclophosphamide and BCG in the treatment of metastatic breast cancer.
Hortobagyi GN; Blumenschein GR; Tashima CK; Buzdar AU; Burgess MA; Livingston RB; Valdivieso M; Gutterman JU; Hersh EM; Bodey GP
Cancer; 1979 Aug; 44(2):398-405. PubMed ID: 383255
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide, with or without Bacillus Calmette-Guerin and with or without irradiation in operable breast cancer. A prospective randomized trial.
Buzdar AU; Blumenschein GR; Smith TL; Powell KC; Hortobagyi GN; Yap HY; Schell FC; Barnes BC; Ames FC; Martin RG
Cancer; 1984 Feb; 53(3):384-9. PubMed ID: 6362814
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant chemoimmunotherapy following regional therapy for isolated recurrences of breast cancer (stage IV NED).
Buzdar AU; Blumenschein GR; Smith TL; Tashima CK; Hortobagyi GN; Yap HY; Gutterman JU; Hersh EM; Gehan EA
J Surg Oncol; 1979; 12(1):27-40. PubMed ID: 480951
[TBL] [Abstract][Full Text] [Related]
17. Postoperative adjuvant chemotherapy with fluorouracil, doxorubicin, cyclophosphamide, and BCG vaccine. A follow-up report.
Buzdar AU; Blumenschein GR; Gutterman JU; Tashima CK; Hortobagyi GN; Smith TL; Campos LT; Wheeler WL; Hersh EM; Freireich EJ; Gehan EA
JAMA; 1979 Oct; 242(14):1509-13. PubMed ID: 470088
[TBL] [Abstract][Full Text] [Related]
18. Alternating noncross-resistant combination chemotherapy and active nonspecific immunotherapy with BCG or MER-BCG for advanced breast carcinoma.
Blumenschein GR; Hortobagyi GN; Richman SP; Gutterman JU; Tashima CK; Buzdar AU; Burgess MA; Livingston RB; Hersh EM
Cancer; 1980 Feb; 45(4):742-9. PubMed ID: 6986970
[TBL] [Abstract][Full Text] [Related]
19. Combination of cyclophosphamide, adriamycin and platinum (CAP) versus 5-fluorouracil, adriamycin and cyclophosphamide (FAC) as primary treatment in metastatic breast cancer: results of a prospective randomized study.
Kolarić K; Vukas D; Potrebica V
Tumori; 1989 Apr; 75(2):132-6. PubMed ID: 2741218
[TBL] [Abstract][Full Text] [Related]
20. Combined antiestrogen and cytotoxic therapy with pseudomonas vaccine immunotherapy for metastatic breast cancer. A prospective, randomized trial.
Hortobagyi GN; Buzdar AU; Frye D; Hug V; Fraschini G; Ames FC; Montague E; Gutterman JU; Martin RG
Cancer; 1987 Dec; 60(11):2596-604. PubMed ID: 3315173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
